Arkansas Children’s Cancer and Blood Disorders Center team manages an average of 11,000 visits annually and treats over 250 active patients with cancer or blood disorders. Since 2021, they have completed 28 allogeneic bone marrow transplants, and in May 2021 alone, they completed 22 autologous stem cell transplants. As a member of Children’s Oncology Group, the team participates in clinical trials through the National Cancer Institute, giving patients access to advanced programs like “Passport of Care”. In recent advancements, they joined the National Marrow Donor program as a transplant center and became part of the Pediatric Transplantation and Cellular Therapy Consortium. The team has successfully reduced C. diff infections from 24 cases in two years to just one since May 2023, resulting in a $552,000 savings in healthcare costs. With 26 private beds and 13 board-certified pediatric hematologists/oncologists, the program continues to innovate in pediatric cancer and blood disorder treatment.
